China Pharma Holdings, Inc.
CPHI
$0.65
-$0.01-1.39%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.22M | -651.50K | -528.40K | -785.60K | -1.22M |
| Total Depreciation and Amortization | 573.00K | 356.00K | 320.90K | 329.30K | 507.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.65M | 109.20K | 211.60K | 212.10K | -10.10K |
| Change in Net Operating Assets | 14.45M | -50.80K | 287.00K | 186.40K | 1.03M |
| Cash from Operations | 152.00K | -237.00K | 291.10K | -57.80K | 298.80K |
| Capital Expenditure | -500.00 | -600.00 | 100.00 | -58.30K | -19.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.30K | -40.00K | -10.00K | -22.60K | -253.30K |
| Cash from Investing | -5.80K | -40.60K | -9.90K | -81.00K | -272.90K |
| Total Debt Issued | 707.60K | -740.20K | 993.70K | -- | 6.80K |
| Total Debt Repaid | -780.20K | 618.00K | -1.02M | -76.80K | -61.10K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -6.80K | 6.80K | -- |
| Cash from Financing | -72.60K | -122.20K | -29.20K | -70.00K | -54.30K |
| Foreign Exchange rate Adjustments | 3.90K | 42.40K | -39.60K | -5.40K | -63.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.50K | -357.40K | 212.30K | -214.20K | -91.80K |